Anna‐Birgitte Aga

Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial

Espen A. Haavardsholm, Anna‐Birgitte Aga, Inge Christoffer Olsen et al. · BMJ · 2016 · 291 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000–2010

Anna‐Birgitte Aga, Elisabeth Lie, Till Uhlig et al. · Annals of the Rheumatic Diseases · 2013 · 184 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +15

Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EULAR criteria

Lena Bugge Nordberg, Siri Lillegraven, Elisabeth Lie et al. · Annals of the Rheumatic Diseases · 2016 · 116 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +17

Comparing the disease course of patients with seronegative and seropositive rheumatoid arthritis fulfilling the 2010 ACR/EULAR classification criteria in a treat-to-target setting: 2-year data from the ARCTIC trial

Lena Bugge Nordberg, Siri Lillegraven, Anna‐Birgitte Aga et al. · RMD Open · 2018 · 71 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis

Maria Karolina Jonsson, Nina Paulshus Sundlisæter, Hilde Haugedal Nordal et al. · Annals of the Rheumatic Diseases · 2017 · 63 citations

Medicine, Clinical Sciences, Internal Medicine +17